Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02565017 · ClinicalTrials.gov registry record
Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 70
- Enrollment target
NCT02565017: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02565017 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02565017 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.
Interventions
- BEHAVIORAL Focus groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2015-09-15 |
| Est. Completion | 2020-06-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02565017
The ClinicalTrials.gov registry entry for NCT02565017 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focus groups is the first listed.
NCT02565017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02565017 about?
NCT02565017 is a clinical study titled "Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System". The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have ...
What is the current status of trial NCT02565017?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2015-09-15. Estimated completion is 2020-06-22.
What interventions are being tested in trial NCT02565017?
The interventions under investigation include: Focus groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT02565017?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.